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1. Introduction
   Chronic cerebral hypoperfusion, a moderate (20%-40%) 
but persistent reduction in cerebral blood flow (CBF), has 
been associated with many brain and vascular pathologies 
such as age-related disorders, cerebrovascular diseases, 
hypoxic-ischemic brain injury, carotid artery pathologies[1]. 
It has been suggested that chronic cerebral hypoperfusion 
plays a critical role in the pathological process of 
neurodegeneration and cognitive impairment, which 
negatively impact the quality of life in humans[2].
  
Permanent occlusion of bilateral common carotid 
arteries (Permanent BCCAO) in rats is a chronic cerebral 
hypoperfusion model that results in significant reduction 
of cerebral blood flow and can cause learning and memory 
impairment, neuronal damage as well as biochemical 
alterations due to oxidative stress resembling the effects 
observed in vascular dementia[3].
  This model is useful to understand the pathophysiology of 
chronic cerebrovascular disorders and to screen drugs with 
potential therapeutic value in vascular dementia[4]. Long-
term cerebral hypoperfusion induced by permanent BCCAO 
causes reduction of blood flow from about 30%-45% in the 
cortex and about 20% in the hippocampus with resultant 
decrease in glucose utilization by 20%-30% and 15%, 
respectively[5]. This chronic reduction in blood flow has 
been repeatedly shown to persist to a significant level for at 
least one month after permanent BCCAO and contributes to 
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behavioral and cognitive deficits[6].
  During the last two decades, pharmacotherapy with 
psychoactive drugs has been increasingly recognized 
as most effective in the management of anxiety, stress 
and psychosomatic and cerebral disorders. However, 
the prolonged use of synthetic drugs leads to a variety 
of autonomic, endocrine, allergic, hematopoietic and 
neurological side effects. Moreover, such agents primarily 
relieve the symptoms and offer a palliative relief of a 
temporary nature[7]. In recent years, there has been a 
phenomenal rise in the interest of scientific community 
to explore the pharmacological actions or to confirm the 
veracity of claims made about herbs in various official 
books of herbal medicine. In today’s life of stress and 
strain, there is a need for agents having neuroprotective 
and neuropharmacological activity enhancing learning 
and memory function of the brain[8]. Phoenix dactylifera 
(P. dactylifera) (date palm) belonging to family Arecaecae 
is considered to be the most important fruit tree in most of 
the Arabian countries[9]. In local medicinal practices date 
fruits are considered as tonic and aphrodisiac, and in some 
communities they are thought to be useful against ulcer. 
In fact, muslims believe that ”He who eats seven dates 
every morning will not be affected by poison or magic on 
the day he eats them”[10]. Different parts of this plant are 
traditionally claimed to be used for the treatment of a broad 
spectrum of ailments including memory disturbances, fever, 
loss of consciousness and nervous disorders[11,12]. Several 
studies indicate that consumption of fruits and vegetables is 
associated with reduced risk of several chronic diseases[13]. 
P. dactylifera (PD) fruits have been documented possess 
antioxidant activity due to the presence of water-soluble 
compounds with potent free radical-scavenging effects, 
such as phenolic compounds (mainly cinnamic acids) and 
flavonoids (flavones, flavonols and flavanones)[14]. PD fruits 
are proved to possess carotenoid content, consumption 
of which has been related to prevention of cancer, 
cardiovascular diseases and other degenerative processes 
involving oxidative stress. The plant is scientifically 
documented for its antiulcer, anticancer, anti-diarrhoeal, 
hepatoprotective, antimutagenic, antioxidant, aphrodiasiac, 
antiinflamatory, antimicrobial, antihyperlipidemic and 
nephroprotective properties but it has yet not been 
evaluated for its antioxidant and neuroprotective activity 
against permanent BCCAO[15]. Therefore the present 
investigation was carried out to evaluate the antioxidant 
and neuroprotective activity of Methanolic extract of 
P. dactylifera fruits MEPD against permanent BCCAO.
2. Materials and methods
2.1. Plant material
  Fresh fruits of P. dactylifera were collected from local 
market and authenticated by Botanical survey of India 
(Voucher specimen number: BSI/WC/Tech/2009/674). The 
methanolic extract of dried fruits was prepared in the 
approved laboratories of Green Chem, Bangalore, India using 
procedure mentioned below.
2.2. Preparation of extract
  The P. dactylifera fruits were manually separated from the 
pits, crushed and cut into small pieces with a sharp knife 
and dry blended for 3 min using a stainless-steel blender. 
Then they were extracted with methanol-water (4:1, v/v), at 
room temperature (20 曟 for 5 h using an orbital shaker). The 
extracts were then filtered and centrifuged at 4 000 g, for 10 
min and the supernatant was concentrated under reduced 
pressure at 40 曟 for 3 h using a rotary evaporator to obtain 
the methanolic extract. The crude extract was kept in dark 
glass bottles for three days inside the freezer until use.
2.3. Chemicals and drugs
  Thiobarbituric acid and trichloroacetic acid were 
purchased from SD fine chemicals, Mumbai, India. 
Nicotinamide adenine dineuleotide phosphate (NADPH), 
oxidized glutathione and reduced glutathione were 
purchased from Vijay chemicals, Pune, India. Bovine serum 
albumin was purchased from Spacelab, Nashik India. 
Phenazine methosulphate, nitroblue tetrazolium, 1-chloro 
2,4 dinitrobenzoic acid were purchased from Anand 
agencies, Pune, India. NADH, Folin Ciocalteau reagents were 
purchased from Bansal sales, Pune, India. Other chemicals 
and solvents used were of analytical grade purchased from 
commercial suppliers.
2.4. Animals
  Wistar rats weighing 200-250 g were used. They were caged 
in a room under standard laboratory conditions (temperature 
(23依1) 曟, relative humidity (55依5)% and lighting 08:00-20:00 
h). The rats were fed on a pelleted diet (Amrut feed, Pune, 
India) and water ad libitum. The rats were transferred to the 
laboratory at least 1h before the start of the experiment. The 
experiments were performed during day (08:00-16:00 h).
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2.5. Ethical clearence
  All the studies were carried out in accordance with 
the guidelines given by the Indian Council for Medical 
Research and the Committee for the Purpose of Control and 
Supervision of Experiments on Animals (CPCSEA), New 
Delhi (India) and the Institutional Animal Ethical Committee 
approved the study (Approval No.: CPCSEA/IAEC/PC-04/07-
2K8).
2.6. Preliminary phytochemical analysis
  The extract was subjected to preliminary screening, 
for various active phytochemical constituents such as 
alkaloids, carbohydrates, steroids, protein, tannins, phenols, 
flavonoids, gum and mucilage, glycosides, saponins and 
terpenes by standard procedures[16].
2.7. Preliminary acute toxicity test
  Healthy adult male albino mice (18-22 g) were subjected 
to acute toxicity studies as per guidelines (AOT 425) 
suggested by the organization for economic co-operation 
and development (OECD-2000). The mice were observed 
continuously for 2 h for behavioral and autonomic profiles 
and for any sign of toxicity or mortality up to a period of 
seven days[17].
2.8. Experimental protocols
  The rats were divided into five groups of 06 each. First 
group served as sham-operated control group and received 
vehicle i.e. distilled water. Second group also received 
distilled water and served as permanent BCCAO control 
group. Third, fourth and fifth groups served as test groups 
i.e. drug treated permanent BCCAO groups and received 
MEPD at doses of 30, 100 and 300 mg/kg respectively. All 
rats except sham operated were subjected to permanent 
BCCAO for 15 d. Treatment with either vehicle or MEPD (30, 
100, 300 mg/kg) was started at 60 min after the surgery and 
continued for 15 d. On 15th day all rats were subjected to 
the behavioural studies i.e. open field test and morris water 
maze test. After behavioural study all the animals were 
sacrificed and their brains were isolated and subjected to 
biochemical analysis and histopathological evaluation[18].
2.9. Surgical procedure for permanent BCCAO
  Surgical procedures were performed between 8:00 a.m. 
and 1:00 p.m. All the surgical equipments and surgical 
pad were disinfected with 70% ethanol before the surgery 
to avoid any kind of infection and sepsis. Rats were 
fasted overnight and at the time of experiment, they were 
anaesthetised by an intraperitoneal injection of 100 mg/kg
ketamine and supplemented as needed. A median incision 
was performed in the skin of the ventral part of the neck 
and the subcutaneous adipose tissue was dissected avoiding 
the thyroid. The omohyoid muscle was cut through a 
median incision and a dissection was made between the 
sternocleidomastoid and the sternohyoid muscles parallel to 
the trachea. Each carotid artery was freed from its adventitial 
sheath and vagus nerve, which was carefully separated 
and maintained. The induction of permanent BCCAO was 
performed by permanently occluding bilateral common 
carotid arteries. The carotid arteries were doubly ligated 
with 3-0 silk sutures and cut in between. The skin was then 
sutured with 3-0 silk suture. Sham control animals received 
the same surgical procedures, except bilateral common 
carotid arteries were not occluded. Core temperature (rectal) 
was maintained at (37.0依0.5) 曟 throughout the surgical 
process using a heating lamp. After the survival surgery the 
antiseptic povidone iodine was applied to the neck incision 
area of all the animals to avoid infection and they were 
returned to their home cages with free access to feed and 
water[18].
2.10. Behavioral testing
2.10.1. Open field test
  Locomotor activity was evaluated in an open field 
paradigm[19]. The open field was made of plywood and 
consisted of a floor (96 cm伊96 cm) with high walls (61 cm 
伊 61cm). Entire apparatus was painted white except for 6 
mm thick blacklines that divided the floor into 16 squares. 
During the experimentation the field was illuminated with 
two 40 W light bulbs. Each animal was placed at one corner 
of the apparatus. After 1 min adaptation, the behavior of 
each animal was recorded for 5 min by two observers 1 m 
away from the open-field area. During the trial intervals, 
the animals were returned to their home cages in the same 
room and the open field was wiped clean with a slightly 
damp cloth. The behavioral parameters were analysed as the 
following:
•Ambulations: the number of grids crossed in the arena 
during the observation period.
•Rearings: the number of times the mouse stands on its hind 
legs.
•Groomings: the number of times the mouse washes itself 
by licking, wiping, combing or scratching of any part of the 
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body.
•Immobility: Total time for which the animal freezes without 
making any movement.
•Number of feacal pellets.
2.10.2. Morris water maze
  Cognitive function was tested in the Morris water maze[20]. 
The maze consisted of a black circular pool (1.2 m diameter, 
40 cm height) filled to a depth of 20 cm with water (22依
1) 曟. At the beginning of each day, the water was made 
opaque by adding milk to prevent the animals from seeing 
the submerged platform. On 14th day after surgery the rats 
received habituation (exposure in water maze for 1 min) in 
which there was no platform present. Then, on day 15th, 
a circular platform (14 cm diameter) was submerged 2 cm 
below the surface of the water in the center of one of the 
quadrants and hidden from the rat’s view. Four points, 
equally spaced along the circumference of the pool, were 
arbitrarily assigned as North, South, East, and West. The 
pool, therefore, was divided into four quadrants (Northeast, 
Southeast, Southwest, and Northwest). These points served 
as the starting positions for the rat being gently lowered into 
the water, with its head facing the wall of the water maze. 
The platform remained in the same position during training 
days (reference memory procedure). All animals followed 
this sequence for that session. Each rat was placed in the 
water facing the wall at the start location and was allowed 
90 s to find the hidden platform. The animal was allowed a 
20 s rest on the platform. The latency to reach the platform 
was recorded. If the rat was unable to locate the hidden 
platform, it was lifted out and placed on the platform for
20 s. The procedure was repeated for all the four start 
locations. Two sessions of four trials each were conducted 
on the first day of testing separated by 4 h and one session 
of four trials was conducted on the next day. After that, the 
platform was removed and a probe trial (without platform) 
was conducted 4 h later. Each rat was placed in the pool at 
the same randomly selected starting pole and swimming path 
was observed and time spent in the quadrant of pool which 
initially contained platform was measured. On completion of 
the probe trial, a black platform that extended 1 cm above 
the surface of water was placed in a quadrant other than 
that chosen for the submerged platform. Each rat was then 
given four trials of 90 s to locate it. The latency to reach the 
platform was recorded (working memory procedure).
2.11. Biochemical analysis
2.11.1. Preparation of brain homogenate
  The rats were sacrificed by decapitation under deep 
anaesthesia on 15th day after behavioural testing. The brains 
were immediately removed, weighed and homogenized 
with 10 times (w/v) ice cold phosphate buffer saline (50 
mM pH 7.0) in a teflon glass homogeniser. The homogenate 
was centrifuged at 2 000 rpm at 4 曟 for 20 min and 
the supernatant was used for measurement of various 
biochemical parameters[21].
2.11.2. Estimation of total protein in the brain
  The total protein content in tissue homogenates was 
measured following the method of Lowry et al. using bovine 
serum albumin as a standard[22].
2.11.3. Measurement of lipid peroxidation (LPO)
  As a measure of lipid peroxidation, malonaldialdehyde 
(MDA) levels were estimated spectrophotometrically by 
measuring thiobarbituric acid reactive substances (TBARS) 
at 532 nm[23].
2.11.4. Estimation of superoxide dismutase (SOD)
  Superoxide dismutase activity was determined 
spectrophotometrically by measuring the inhibition of 
reduction of NBT to blue-colored chromogen in the presence 
of PMS and NADH by SOD at 560 nm[24].
2.11.5. Estimation of catalase (CAT)
  C a t a l a s e  m e a s u r e m e n t  w a s  c a r r i e d  o u t 
spectrophotometrically by measuring the ability of CAT to 
oxidize hydrogen peroxide (H2O2) at 240 nm[25].
2.11.6. Estimation of reduced glutathione (GSH)
  Glutathione was measured spectrophotometrically 
according to the method of Ellman (1959) at 412 nm[26].
2.11.7. Estimation of glutathione peroxidase (GPx)
  Selenium-dependent glutathione peroxidase activity 
was measured spectrophotometrically by monitoring the 
continuous decrease in NADPH concentration using H2O2 as 
a substrate at 340 nm[27].
2.11.8. Estimation of glutathione-S-transferase (GST)
  Glutathione-S-transferase activity was determined by 
monitoring the formation of the thioether product from 
the reaction between GSH and CDNB (1-chloro, 2,4-
dinitrobenzene) at 340 nm[28].
2.11.9. Estimation of glutathione reductase (GR)
  Glutathione reductase activity was assayed by measuring 
the disappearance of NADPH at 340 nm the method of 
Carlberg and Mannervik (1975) at 340 nm[29].
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2.12. Histopathological examination
  The rats were sacrificed by decapitation under deep 
anaesthesia on 15th day after behavioural testing by 
decapitation under deep anesthesia and the brains were 
removed. The intact whole brains were fixed in formalin 
(10%, v/v). The tissue was cut into 3 mm thickness and its 
blocks were embedded in paraffin. The forebrain sections 
(5-10 m) thickness were prepared using a rotary microtome 
and stained with hematoxylin and eosin[21].
2.13. Statistical analysis
  Results were expressed as mean依S.E.M. Statistical analysis 
was performed using oneway analysis of variance (ANOVA). 
If the overall P-value was found statistically significant 
(P<0.05), further comparisons among groups were made 
according to post hoc Tukey’s test. The diagrammatic 
representation of the data was performed by using instat 
software (Graph Pad Instat).
3. Results
3.1. Preliminary phytochemical analysis
  Preliminary phytochemical analysis of MEPD showed 
the presence of steroids, alkaloids, glycosides, flavonoids, 
proteins and carbohydrates.
3.2. Acute toxicity test
  The mice treated with MEPD were found to be free of any 
toxicity upto the dose of 2 000 mg/kg and exhibited normal 
behavior. Mice were alert with normal grooming, touch 
response, pain response and there was no sign of passivity, 
stereotypy and vocalization. There was no abnormal change 
in motor activity, secretory signs as well as their body weight 
and water intake.
3.3. Behavioural testing
3.3.1. Open field test
  In open-field paradigm, rats of permanent BCCAO control 
gorup showed marked alterations in exploratory behavior 
as compared to those of sham operated group. The number 
of ambulations were significantly (P<0.001) decreased in 
permanent BCCAO control group rats as compared to sham 
operated group rats. This decrease was significantly (P<0.01, 
P<0.001) ameliorated by treatment with MEPD 100 and 300 
mg/kg. Permanent BCCAO for 15 days produced a significant 
(P<0.01) reduction in number of rearings in permanent 
BCCAO control group rats as compared to sham operated 
group rats. Treatment with MEPD 100 and 300 mg/kg 
significantly (P<0.05) attenuated this decrease. A significant 
(P<0.01) reduction in number of groomings was also observed 
in permanent BCCAO group rats in comparison with sham 
operated group rats. This reduction was significanlty 
(P<0.05) overcomed by treatment with MEPD 300 mg/kg. 
Accompanying this alteration in exploratory activities, the 
period of immobility was significantly (P<0.001) increased 
in permanent BCCAO control group rats and they exhibited 
more freezing behavior as compared to sham operated group 
rats. Treatment with MEPD 100 and 300 mg/kg significantly 
(P<0.05, P<0.01) attenuated increase in duration of 
immobility. However, no difference between the groups was 
observed for number of fecal pellets. The dose 30 mg/kg was 
nonsignificant in reversing the behavioural alterations (Table 
1).
3.3.2. Morris water maze test
  In the first session of escape latency trial, wherein the 
latency to locate the submerged platform was assessed, no 
significant difference was observed between the groups. The 
escape latencies of sham operated group rats, permanent 
BCCAO control group rats, MEPD 30, 100 and 300 mg/kg 
treated permanent BCCAO group rats in the first session 
of morris water maze test were (63.00依10.78), (75.90依6.67), 
(68.63依7.35), (66.38依9.57) and (66.77依7.68) respectively. In the 
Table 1
Effect of MEPD on the ambulations, rearings, groomings and time of immobility in open field test of rats subjected to permanent BCCAO.
Group Ambulations Rearings Groomings Duration of immobility Fecal pellets
Sham operated 74.33依5.76 30.16依4.30   8.66依1.05   25.16依5.10 2.00依0.57
Permanent BCCAO control 24.83依2.86*** 13.16依2.38*** 19.00依1.26*** 102.33依9.02*** 2.83依0.60
PD 30 + Permanent BCCAO 30.83依3.53 27.50依4.85 13.16依2.05   74.00依11.81 2.50依0.42
PD 100 + Permanent BCCAO 48.16依2.62## 29.50依3.33# 12.33依2.26#   66.50依6.26# 2.00依0.57
PD 300 + Permanent BCCAO 56.66依4.37### 36.67依3.30# 13.00依2.28##   58.33依8.42## 2.50依0.42
Results are expressed as mean + SEM. Comparison between the groups was made by one way analysis of variance (ANOVA) followed by Tukey’s 
test *,#-P<0.05, **,##-P<0.01, ***,###-P<0.001; *- Permanent BCCAO control group against sham operated; #- MEPD treated  ischemia 
group against permanent BCCAO control group.
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second session, the latency to reach the submerged platform 
i.e. escape latency in permanent BCCAO control group 
rats was significantly (P<0.01) higher as compared to sham 
operated group rats. The escape latencies of sham operated 
group rats, permanent BCCAO control group rats, MEPD 30, 
100 and 300 mg/kg treated permanent BCCAO group rats 
in the second session of morris water maze test were (29.47
依3.99), (71.931依5.67), (63.64依9.67), (40.17依8.92) and (33.51
依6.99) respectively. Whereas, MEPD 100 and 300 mg/kg 
treated permanent BCCAO group rats required significantly 
(P<0.05, P<0.01) less time to locate the submerged platform 
when compared with permanent BCCAO control group rats. 
Similarly, in third session also permanent BCCAO control 
group rats took longer time to find the submerged platform 
as compared to sham operated group rats, and this increase 
in escape latency was attenuated significantly (P<0.01) by 
the treatment with MEPD 100 and 300 mg/kg. The escape 
latencies of sham operated group rats, permanent BCCAO 
control group rats, MEPD 30, 100 and 300 mg/kg treated 
permanent BCCAO group rats in the third session of morris 
water maze test were (27.51依4.52), (69.31依4.80), (46.93依9.05), 
(33.21依6.55) and (32.92依6.53) respectively (Figure 1).
 
Figure 1. Effect of MEPD on the escape latency in morris water maze 
test of rats subjected to permanent BCCAO.
Results are expressed as mean + SEM. Comparison between the 
groups was made by one way analysis of variance (ANOVA) followed 
by Tukey’s test *,#-P<0.05, **,##-P<0.01, ***,###- P<0.001; 
*-Cerebral Ischemia control group against sham operated; #- MEPD 
treated  ischemia group against Cerebral Ischemia control group.
  In the probe trial, a significant difference in the spatial 
bias of rats towards the quadrant of pool that contained the 
submerged platform during the escape latency sessions 
was observed. The time spent by sham operated group rats, 
permanent BCCAO control group rats, MEPD 30, 100 and 300 
mg/kg treated permanent BCCAO group rats in the quadrant 
of the initial platform position were (53.60依5.99), (20.24依3.34), 
(27.23依4.07), (51.31依11.06) and (52.61依9.55) respectively. The 
permanent BCCAO control group rats spent a significantly 
(P<0.05) less time in the quadrant of the initial platform 
position than sham operated group rats. Treatment with 
MEPD 300 mg/kg significantly increased the time spent in 
the quadrant of the initial platform position in comparison 
with permanent BCCAO control group rats (Figure 2).
  The new platform trial demonstrated that the permanent 
BCCAO control group rats took significantly (P<0.01) longer 
time in reaching the submerged platform as compared to 
sham operated group rats. Whereas, the latency to reach 
submerged platform was significantly lessened in the MEPD 
100 and 300 mg/kg treated rats. The escape latencies of 
sham operated group rats, permanent BCCAO control group 
rats, MEPD 30, 100 and 300 mg/kg treated permanent BCCAO 
group rats in the new platform trial of morris water maze test 
were (27.38依5.78), (69.73依4.12), (51.35依10.61), (34.26依9.93) and 
(25.21依6.36) respectively (Figure 2).
 
Figure 2. Effect of MEPD on the escape latency in probe trial and 
new platform trial tests in morris water maze test of rats subjected to 
permanent BCCAO.
Table 2
Effect of MEPD on MDA, CAT and SOD levels in the brains of the rats subjected to permanent BCCAO.
Groups        MDA (U/mg protien)          CAT  (U/mg protien)         SOD (U/mg protien)
Sham operated 1.56依0.43 1.81依0.05 4.68依0.28
Permanent BCCAO control    3.84依0.52***    0.73依0.04***    1.82依0.11***
MEPD 30 + Permanent BCCAO 4.13依0.71 0.95依0.04  3.64依0.62#
MEPD 100 +  Permanent BCCAO  2.15依0.82#    1.37依0.11###  3.63依0.37#
MEPD 300 +  Permanent BCCAO   1.74依0.85##    1.70依0.16###   4.18依0.35##
Results are expressed as mean 依 SEM. (n = 6). Data was analysed by one way analysis of variance (ANOVA) followed by Tukey’s test. 
*,#P<0.05, **,##P<0.01, ***,###P<0.001. Permanent BCCAO control group rats compared against sham operated rats; #-MEPD treated 
permanent BCCAO group rats compared permanent BCCAO control group rats.
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  Results are expressed as mean + SEM. Comparison 
between the groups was made by one way analysis of 
variance (ANOVA) followed by Tukey’s test *,#-P<0.05, 
**,##-P<0.01, ***,###-P<0.001; *-Permanent BCCAO 
control group against sham operated; #- MEPD treated 
ischemia group against permanent BCCAO control group.
3.4. Biochemical analysis
3.4.1. Measurement of lipid peroxidation (LPO)
  The permanent BCCAO for 15 days produced a significant 
(P<0.001) rise in the malonaldialdehyde (MDA) levels of 
permanent BCCAO control group as compared to sham 
operated group, MEPD (100 and 300 mg/kg) treated 
permanent BCCAO group showed significantly (P<0.05, 
P<0.01) lowered MDA levels in comparison with permanent 
BCCAO control group rats. The dose 30 mg/kg was found to 
be ineffective in this regard (Table 2).
3.4.2. Estimation of superoxide dismutase (SOD)
  SOD levels in the brains of permanent BCCAO control 
group rats were significantly lowered as compared to sham 
operated rats. 15 days post occlusion treatment with MEPD 
(30, 100 and 300 mg/kg) significantly (P<0.05, P<0.05, P<0.01) 
reversed this decrease in comparison with permanent 
BCCAO control group rats (Table 2).
3.4.3. Estimation of catalase (CAT)
  There was a significant (P<0.001) reduction in the CAT 
levels in the brains of permanent BCCAO control group 
rats as compared to sham operated rats. MEPD (100 and 300 
mg/kg) significantly (P<0.001) attenuated this reduction in 
comparison with permanent BCCAO control group rats. The 
dose 30 mg/kg was found to be ineffective in this regard 
(Table 2).
3.4.4. Estimation of reduced glutathione (GSH)
  Reduced glutathione (GSH) levels in brains of sham 
operated rats, permanent BCCAO control group rats. 
Permanent BCCAO for 15 d produced a significant (P<0.001) 
decrease in GSH levels in the brains of permanent BCCAO 
control group rats as compared to sham operated rats. 15 
days post occlusion treatment with MEPD (100 and 300 mg/kg)
significantly (P<0.05, P<0.05) attenuated this decrease in 
comparison with permanent BCCAO control group rats (Table 
3).
3.4.5. Estimation of glutathione peroxidase (GPx)
  A significant decrease was found in GPx levels in the 
brains of permanent BCCAO control group rats as compared 
to sham operated rats but none of the doses of MEPD 
showed the ability to increase the decreased levels of GPx 
significantly (Table 3).
3.4.6. Estimation of glutathione-S-transferase (GST)
  Permanent BCCAO for 15 d produced a significant (P<0.001) 
decrease in GST level in the brains of permanent BCCAO 
control group rats as compared to sham operated rats but 
none of the doses of MEPD were significant (P<0.001) in 
reversing the decreased levels of GST (Table 3).
3.4.7. Estimation of glutathione reductase (GR)
  There was a significant reduction in the GR concentration 
in the brains of permanent   BCCAO control group rats as 
compared to sham operated rats. MEPD (100 and 300 mg/
kg) significantly (P<0.05, P<0.01) reversed this decrease in 
comparison with permanent BCCAO control group rats (Table 
3).
3.5. Histopathological examination
  From the histopathological study it was observed that 15 d 
of permanent BCCAO and the effect of MEPD treatment on 
the changes induced. 15 d of permanent BCCAO produced 
severe neuronal damage by atrophy and necrosis of the 
neurons along with vacuole formation in the forebrain 
regions of permanent BCCAO control group rats when 
compared with the sham operated group rats. The treatment 
Table 3
Effect of MEPD on GSH, GST, GPX and GR levels in the brains of the rats subjected to permanent BCCAO.
Groups GSH (U/mg protien) GST(U/mg protien) GPX(U/mg protien) GR(U/mg protien)
Sham operated 119.18依6.94     67.41依5.18    3.44依0.19 6.02依0.20
Permanent BCCAO control      80.59依6.12***        36.60依3.06***        1.03依0.03***     2.34依0.29***
PD 30 + Permanent BCCAO  86.90依5.41     49.72依6.25    1.80依0.39 2.81依0.24
PD 100 + Permanent BCCAO 106.39依5.01#     54.75依5.41    1.85依0.15  3.91依0.45#
PD 300 + Permanent BCCAO 107.26依4.15#     54.07依4.49    1.91依0.22    4.39依0.34##
Results are expressed as mean 依 SEM. (n=6). Data was analysed by one way analysis of variance (ANOVA) followed by Tukey’s test. *,#P<0.05, 
**,##P<0.01, ***,###P<0.001. Permanent BCCAO control group rats compared against sham operated rats; #-MEPD treated permanent BCCAO 
group rats compared permanent BCCAO control group rats.
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with MEPD 100 and 300 mg/kg attenuated these changes as 
compared to the permanent BCCAO control group. MEPD 
30 mg/kg was found inefficient in reversing these changes 
(Figure 3).
 
Figure 3. Representative photomicrographs (H & E stain) of forebrain 
sections of sham operated rats (A), permanent BCCAO control group 
rats (B), MEPD 30, 100 and 300 mg/kg treated permanent BCCAO 
group rats (C, D, E). Rats subjected to permanent BCCAO showed 
morphological alterations suggestive of shrinkage and necrosis of 
neurons and vacuolisation which was attenuated by treatment with 
MEPD 100 and 300 mg/kg.
4. Discussion
  Chronic cerebral hypoperfusion is considered to be a factor 
contributing to the memory dysfunction in neurological 
diseases such as cognitive decline in aging, Alzheimer’s 
disease and vascular dementia. A sudden disruption of the 
blood supply to distinct brain regions leads to stroke, while a 
moderate but persistent reduction in regional cerebral blood 
flow (CBF) compromises memory processes and contributes 
to the development and progression of dementia. The 
association of decreased CBF, particularly in the temporal 
and parietal cortices, with Alzheimer’s disease (AD) has been 
firmly established[3,30,31]. Additionally, the degree or pattern 
of cerebral hypoperfusion in mild cognitive impairment has 
been suggested as a predictive marker for the progression 
to AD. Chronic BCCAO has also been used in behavioral 
studies as an abstracted model of reduced cerebral perfusion 
(chronic hypoperfusion) in aging. Furthermore, cerebral 
hypoperfusion can occur in patients who have suffered 
a cardiac arrest or those who undergo complex cardiac 
surgery, and this condition can lead to a poor neurologic 
outcome[32]. For an understanding of the role of the 
cerebrovascular pathology in the development of a cognitive 
dysfunction and dementia, it is important to explore the 
cerebral hypoperfusion-related metabolic changes, the 
distinct neurodegenerative and cognitive correlates of 
hypoperfusion and the causal relationships between these 
factors. Furthermore, recognition of particular mechanisms 
in the chain of events from chronic cerebral hypoperfusion to 
a cognitive decline may identify potential targets for effective 
therapies. The reconstruction of a pathological condition 
in animal models is a suitable approach to the unraveling 
of causal relationships. For this reason, permanent BCCAO 
in rats has been established as a procedure to investigate 
the effects of chronic cerebral hypoperfusion on cognitive 
dysfunction and neurodegenerative processes. Over the 
years, this model has generated a large amount of data, 
revealing the permanent BCCAO related pattern of cerebral 
hypoperfusion and metabolic changes, cerebrovascular 
insufficiency states, white matter lesions, neurodegenerative 
conditions and learning and memory disturbances, failure 
of neuronal signaling and the neuropathological changes in 
the hippocampus and thus it is considered to be suitable for 
the development of potentially neuroprotective strategies in 
neurodegenerative diseases[32-34].
  The present study was aimed at investigating the potential 
beneficial effects of P. dactylifera on ischemia-induced 
oxidative stress as well as functional and anatomical 
integrity following long-term cerebral hypoperfusion in rats.
It is very well documented that long-term cerebral 
hypoperfusion produces abnormal levels of reactive oxygen 
species which may initiate and sustain the cascade of 
neuropathological events underlying vascular dementia. 
Clinical research findings also indicate reduced antioxidant 
defense involved in the pathophysiology of vascular 
dementia[35]. Therefore we examined the antioxidant enzyme 
levels like MDA, SOD, CAT, GSH, GPx, GST and GR which 
served as oxidative indices in various brain regions of 
the permanent BCCA occluded rats. Excessive generation 
of reactive oxygen species (ROS) results in the lipid 
peroxidation of the cell membrane and subsequent damage 
is reflected by accumulation of MDA, a neurotoxic by-
product of lipid peroxidation[36]. Neural tissue concentrations 
of MDA were assayed as an index of membrane oxidative 
damage. A marked increase in lipid peroxidation indicated 
by increased MDA levels in brain tissues, resulting from 
free-radical generation induced by chronic cerebral 
hypoperfusion, was observed in the present study. These 
increased levels were significantly reversed by chronic 
postischemic treatment with MEPD (100, 300 mg/kg) for 15 d
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which indicates the protective role of MEPD against lipid 
peroxidation. In the present study, decrease in the levels of 
SOD and CAT were noted in brains of the ischemic rats that 
indicated the participation of superoxide radical which is 
known to produce highly toxic hydroxyl radical through its 
reaction with H2O2 (Haber-Weiss reaction) in turn leading to 
decreased SOD through a modification in histidine residue 
located in the active site of the enzyme. On the other hand 
this over production of H2O2 can be scavenged further by 
tissue catalase which leads to reduction in the tissue catalase 
levels[35-37]. MEPD (100 and 300 mg/kg) was found to elevate 
the activity of two major oxygen radical species metabolizing 
enzymes i.e. SOD and CAT in brains of the ischemic rats 
which shows that MEPD possess antioxidant activity against 
hypoperfusion induced oxidative stress. Sulfahydryl groups 
represent an important endogenous antioxidant mechanism. 
They have role in maintenance of cellular proteins and 
lipids in their functional states. When these are consumed, 
the toxic effects of oxidative insult are exacerbated resulting 
in increased membrane and cell damage. Glutathione and 
other protein/nonprotein sulphahydryls are scavengers of 
ROS and help to maintain macromolecular components of 
the cell in their functional status. 
  In the present investigation fall in the levels GSH, 
GPx, GR and GST was observed in the rats subjected to 
cerebral hypoperfusion. Decline in the levels of GSH 
can be attributed to several factors such as cleavage of 
GSH to cysteine, decrease in synthesis of GSH and the 
formation of mixed disulfides with GSSG, causing their 
cellular stores depleted. Glutathione peroxidase along with 
catalase removes hydrogen peroxide and limits the hydroxyl 
radical formation during chronic hypoperfusion whereas 
and glutathione-S-transferase and glutathione reductase 
removes toxic products of ROS damage leading to depletion 
in their levels[38]. Postischemic treatment with MEPD (100, 
300 mg/kg) significantly increased the levels of GSH and 
GR and thus exhibited its ability to restore the altered 
endogenous antioxidant defense system. None of the doses 
of MEPD were found to elevate the decreased levels of GPx 
and GST.
  In evaluations of the potential neuroprotective drug, the 
need for assessing the drug effects on the histological and/
or functional measures of neuronal damage has always 
been emphasized[39,40]. Extensive investigations report 
that rats subjected to permanent occlusion of BCCA show 
impaired spatial learning/memory capabilities and/or 
structural alterations and neuronal damage accompanying 
compromised brain homeostasis resembling the effects 
observed in vascular dementia[41,42].
  In the present study, hypoperfused animals, when 
tested in open-field paradigm, exhibited decreased 
ambulations, rearings and groomings with an increase 
in period of immobility. These findings, according to 
accepted tenets, indicate that the hypoperfused animals 
were more susceptible to develop anxiety when exposed to 
novel environment[19]. MEPD significantly attenuated these 
alterations in exploratory behavior, suggesting that MEPD 
protects against hypoperfusion-induced anxiety.
  Learning was mainly explored by the Water Maze test that 
investigates the ability of a rat to learn a spatial route to 
find a platform hidden in a pool, after a training phase. In 
general, cognition includes at least three primary processes: 
acquisition, consolidation, and retention. The Morris water 
maze is a hippocampus-dependent memory task that has 
been used to assess cognitive deficits in the ischemic brain. 
In the present study, the hidden platform trial measured 
acquisition, the reversal trial measured relearning ability, 
and the probe trial measured retention[20,43,44]. The results 
exhibited that both learning capacity and memory were 
gradually impaired in the rats with chronic cerebral 
hypoperfusion. Long term hypoperfused animals consistently 
took longer time to find the submerged platform reflecting 
a defective learning process. This when combined with the 
results of probe trial and new platform trial reflected the 
disturbances in reference and working memory in long term 
hypoperfused rats. These observations were in accordance 
with earlier reports of hypoperfusion-induced spatial 
learning and memory deficits. It has been suggested earlier 
that such behavioral disturbances may be due to subcellular 
alterations, purely functional and/or transmission failure[45-
47]. MEPD significantly attenuated these alterations 
suggesting its positive role in learning and memory in long 
term hypoperfused rats. Extensive investigations report 
that rats subjected to permanent BCCAO show structural 
alterations and neuronal damage in their brains[48-50].    
  Histopathological changes like shrinkage and necrosis 
of neurons, vacuolisation and inflammatory infiltration 
reflect hypoperfusion induced reactive changes in rat 
brain. These alterations were alleviated by postischemic 
administration of MEPD (100, 300 mg/kg). Attenuation of 
reactive morphological changes as well as behavioral 
deficits by MEPD indicates that it reduces neuronal insult in 
the settings of permanent BCCAO.
  At dose of 30 mg/kg, MEPD was found to be ineffective in 
attenuating any of the biochemical, histopathological as well 
as behavioural changes. Previous reports of phytochemical 
investigations of P. dactylifera fruits have revealed the 
presence of flavonoids which was confirmed in the present 
study by the results of preliminary phytochemical analysis. 
These pharmacophores have been shown to possess potent 
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antioxidant and anti-inflammatory activity[51,52]. The present 
findings suggest that the palliative effect of MEPD on 
cognitive deficits and structural changes is associated with 
its antioxidant activity. 
  In conclusion, in the present study MEPD exhibited 
significant neuroprotection against oxidative stress, neuronal 
damage and spatial learning and memory impairment 
induced by permanent BCCAO and validated its claim 
as neuroprotective drug. The neuroprotective role can be 
attributed to the polyphenolic compounds such as flavonoids 
and plant sterols, ascorbic acid present in the plant. These 
findings suggest a promising role of P. dactylifera in stroke 
and vascular dementia in the Alzheimer’s disease and age 
related memory disturbances. However, further studies 
are needed to elucidate the effects of MEPD on cerebral 
microcirculation in the ischemic brain.
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